Account
Inquiry
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. Our pharmaceutical grade Tirzepatide offers superior efficacy in glucose control studies compared to single agonists.
The compound demonstrates significant weight loss effects in clinical studies, with trial participants showing 15-20.9% reduction in body weight across different dosages. As a research chemical, our Tirzepatide prices remain competitive for bulk orders while maintaining 99.9% purity standards.
Structurally similar to semaglutide but with PEG-modified lysine side chains, Tirzepatide exhibits improved water solubility. This modification enhances its dual agonist activity at both GIP and GLP-1 receptors, making it particularly valuable for metabolic disorder research.
Current tirzepatide prices reflect its status as an investigational compound with FDA Fast Track designation. Researchers can obtain this material in convenient 10mg vials (10 vials/box) for laboratory use only.
